Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study
BelgiumDuchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen
BelgiumNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaAUR200 for Patients with Generalized Myasthenia Gravis
DenmarkBMN 333 Versus Vosoritide in Children With Achondroplasia
FranceTulisokibart for Psoriatic Arthritis in Adults
GermanyIndocyanine Green and Near-Infrared Fluorescence for Lymph Node Removal in Children with Renal Tumours or Paratesticular Rhabdomyosarcoma
The NetherlandsA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
BelgiumA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
BelgiumA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
BulgariaA study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis
GermanyA study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults
PolandThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
